Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 501

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050

Open access
Genitsaridi, Irini, Salpea, Paraskevi, Salim, Agus, Sajjadi, Seyedeh Forough, Tomic, Dunya, James, Steven, Thirunavukkarasu, Sathish, Issaka, Ayuba, Chen, Lei, Basit, Abdul, Luk, Andrea O Y, Ma, Ronald C W, Mbanya, Jean-Claude, Ramachandran, Ambady, Wild, Sarah H, Duncan, Bruce B, Boyko, Edward J, Magliano, Dianna J · 2026 · The Lancet Diabetes & Endocrinology

Abstract

BACKGROUND Diabetes is a major global cause of morbidity and mortality. The aim of the 11th edition of the International Diabetes Federation (IDF) Diabetes Atlas is to provide national, regional, and global diabetes prevalence estimates for 2024, with projections to 2050. METHODS Diabetes (diagnosed and undiagnosed) prevalence among adults aged 20-79 years was estimated in 215 countries and territories, using 246 studies conducted between 2005 and 2024. Studies were filtered by sample size, diagnostic method, study year, representativeness, and publication type. Logistic regression generated 5-year age-specific prevalence estimates stratified by sex and urban-rural location. These estimates were aggregated and standardised to national population distributions to generate national, regional, and global estimates. Extrapolation was applied in countries without in-country data based on others of similar income, geography, ethnicity, and language. FINDINGS In 2024, diabetes affected 11·11% (95% uncertainty interval 11·05-11·17) of the global adult population, corresponding to 589 million adults (587-591), and is projected to affect 12·96% (12·91-13·02) and 853 million (851-856) people aged 20-79 years by 2050. Prevalence peaked at 24·79% (23·53-26·05) among those aged 75-79 years and was 23·72% (23·67-23·77) in adults aged >65 years. Prevalence was higher in males than females (11·55% [11·43-11·66] vs 10·68% [10·57-10·79]) and in urban than rural areas (12·26% [12·14-12·38] vs 9·23% [9·15-9·31]). Middle-income countries had the highest prevalence (11·46% [11·30-11·63]), followed by high-income (10·21% [9·91-10·50]) and low-income (7·47% [7·17-7·76]) countries. INTERPRETATION In 2024, one in nine adults worldwide was living with diabetes. The number of adults with diabetes in 2024 exceeded 500 million and is projected to rise to close to 900 million by 2050. As the diabetes epidemic has continued unchecked since the turn of the millennium, stronger efforts are needed to slow its progression, with strategies tailored appropriately across countries and population groups. FUNDING Sanofi, Novo Nordisk, MSD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(25)00299-2

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Metadata

Authors
Genitsaridi, I., Salpea, P., Salim, A., Sajjadi, S. F., Tomic, D., James, S., Thirunavukkarasu, S., Issaka, A., Chen, L., Basit, A., Luk, A. O. Y., Ma, R. C. W., Mbanya, J.-C., Ramachandran, A., Wild, S. H., Duncan, B. B., Boyko, E. J., & Magliano, D. J.
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2026-02
Volume
14
Issue
2
Pages
149-156
ISSN
2213-8587 (ISSN-L)
OpenAlex
W4417523995
Cited by
501
References
16
FWCI
298.33
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. https://app.cochat.ai/papers/10.1016/s2213-8587(25)00299-2
The paper
Genitsaridi, I., Salpea, P., Salim, A., Sajjadi, S. F., Tomic, D., James, S., Thirunavukkarasu, S., Issaka, A., Chen, L., Basit, A., Luk, A. O. Y., Ma, R. C. W., Mbanya, J.-C., Ramachandran, A., Wild, S. H., Duncan, B. B., Boyko, E. J., & Magliano, D. J. (2026). 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(25)00299-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.